TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

EMA Fails to Follow Legislation and Its Own Policy, page-13

  1. CroMagnon
    264 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    06/11/14
    17:48
    Post #: 14247674
    hvalfisken
    - you forgot GlaxoSmithKline and AstraZeneca and Pfizer and Novartis and Hoffman-La Roche and Genentech and Eli Lilly and .... and ....
    The last five being prime candidates for obstructing the upcoming FDA trials.
    TIS Price at posting: 30.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS MTM and Indium form strategic collaboration for recovering Gallium and Germanium
right-arrow Created with Sketch.
NEWS High grade drill results discovered at CODA North
right-arrow Created with Sketch.
NEWS Significant milestone reached in Zimbabwe's oil and gas exploration industry as Invictus Energy moves closer to execution
right-arrow Created with Sketch.
MKG Encouraging results for Raiden as Pegmatite extensions confirmed
right-arrow Created with Sketch.
NEWS Experienced CEO appointed to Indiana Resources
right-arrow Created with Sketch.
NEWS Share Purchase Plan by robotic technology company now complete
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.